4-chlorobenzenesulfonylurea: chlorpropamide metabolite [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 89785 |
| CHEMBL ID | 3184360 |
| CHEBI ID | 143297 |
| SCHEMBL ID | 7264925 |
| MeSH ID | M0110874 |
| Synonym |
|---|
| 4-chlorobenzenesulfonyl urea |
| 4-chlorobenzenesulfonylurea |
| FT-0659281 |
| CHEBI:143297 |
| 22663-37-2 |
| (4-chlorophenyl)sulfonylurea |
| AKOS003617549 |
| (4-chlorophenylsulfonyl)urea |
| C2266 |
| para-chlorobenzene-sulfonylurea |
| n-(aminocarbonyl)-4-chlorobenzenesulphonamide |
| einecs 245-149-4 |
| A816302 |
| n-carbamoyl-4-chlorobenzenesulfonamide |
| (4-chlorobenzenesulfonyl)urea |
| PS-3667 |
| NCGC00253634-01 |
| cas-22663-37-2 |
| dtxsid8057691 , |
| tox21_113761 |
| 1-(4-chlorobenzenesulfonyl)urea |
| dtxcid9031480 |
| SCHEMBL7264925 |
| 4-chlorobenzenesulphonyl urea |
| mfcd00518656 |
| p-chlorobenzenesulphonylurea |
| W-107462 |
| benzenesulfonamide, n-(aminocarbonyl)-4-chloro- |
| CHEMBL3184360 |
| [(4-chlorobenzene)sulfonyl]urea |
| p-chlorobenzene sulfonyl urea |
| sr-01000944809 |
| SR-01000944809-1 |
| 1-(((aminocarbonyl)amino)sulfonyl)-4-chlorobenzene |
| 4-chloro phenylsulfonyl urea |
| 4-chlorophenylsulfonyl urea |
| CS-0204291 |
| 4-chlorophenylsulfonylurea |
| T70597 |
| Class | Description |
|---|---|
| sulfonamide | An amide of a sulfonic acid RS(=O)2NR'2. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| GLI family zinc finger 3 | Homo sapiens (human) | Potency | 10.5909 | 0.0007 | 14.5928 | 83.7951 | AID1259369 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID1347090 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for DAOY cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347107 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh30 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347093 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-MC cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347097 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Saos-2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347100 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for LAN-5 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347105 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for MG 63 (6-TG R) cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347089 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for TC32 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID651635 | Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression | |||
| AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1 | Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
| AID1347104 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for RD cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347094 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-37 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347101 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for BT-12 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347096 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for U-2 OS cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347092 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for A673 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347103 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for OHS-50 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347102 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh18 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1508630 | Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay | 2021 | Cell reports, 04-27, Volume: 35, Issue:4 | A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. |
| AID1745845 | Primary qHTS for Inhibitors of ATXN expression | |||
| AID1347154 | Primary screen GU AMC qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49 | Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
| AID1347424 | RapidFire Mass Spectrometry qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46 | Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1347086 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347095 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB-EBc1 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347098 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SK-N-SH cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347108 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for Rh41 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347091 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for SJ-GBM2 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347083 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347106 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for control Hh wild type fibroblast cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| AID1347407 | qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Pharmaceutical Collection | 2020 | ACS chemical biology, 07-17, Volume: 15, Issue:7 | High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle. |
| AID1347082 | qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal | 2020 | Antiviral research, 01, Volume: 173 | A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity. |
| AID1347425 | Rhodamine-PBP qHTS Assay for Modulators of WT P53-Induced Phosphatase 1 (WIP1) | 2019 | The Journal of biological chemistry, 11-15, Volume: 294, Issue:46 | Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. |
| AID1347099 | qHTS of pediatric cancer cell lines to identify multiple opportunities for drug repurposing: Primary screen for NB1643 cells | 2018 | Oncotarget, Jan-12, Volume: 9, Issue:4 | Quantitative high-throughput phenotypic screening of pediatric cancer cell lines identifies multiple opportunities for drug repurposing. |
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 6 (75.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 9 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Substance | Description | Relationhip Strength | Studies | Trials | Classes | Roles |
|---|---|---|---|---|---|---|
| chlorpropamide | [no description available] | medium | 1 | 0 | monochlorobenzenes; N-sulfonylurea | hypoglycemic agent; insulin secretagogue |
| acetazolamide | [no description available] | low | 0 | 0 | monocarboxylic acid amide; sulfonamide; thiadiazoles | anticonvulsant; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| 1-(4-methanesulfonamidophenoxy)-3-(n-methyl-3,4-dichlorophenylethylamino)-2-propanol | [no description available] | low | 0 | 0 | sulfonamide | |
| amosulalol | [no description available] | low | 0 | 0 | sulfonamide | |
| ampiroxicam | [no description available] | low | 0 | 0 | acetal; aminopyridine; benzothiazine; etabonate ester; monocarboxylic acid amide; sulfonamide | analgesic; antirheumatic drug; EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor; non-steroidal anti-inflammatory drug; prodrug |
| amsacrine | [no description available] | low | 0 | 0 | acridines; aromatic ether; sulfonamide | antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor |
| azosemide | [no description available] | low | 0 | 0 | monochlorobenzenes; sulfonamide; tetrazoles; thiophenes | loop diuretic |
| bendroflumethiazide | [no description available] | low | 0 | 0 | benzothiadiazine; sulfonamide | antihypertensive agent; diuretic |
| benzothiazide | [no description available] | low | 0 | 0 | benzothiadiazine; sulfonamide | antihypertensive agent; diuretic |
| benzylhydrochlorothiazide | [no description available] | low | 0 | 0 | benzenes; benzothiadiazine; organochlorine compound; secondary amino compound; sulfonamide | |
| bumetanide | [no description available] | low | 0 | 0 | amino acid; benzoic acids; sulfonamide | diuretic; EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor |
| celecoxib | [no description available] | low | 0 | 0 | organofluorine compound; pyrazoles; sulfonamide; toluenes | cyclooxygenase 2 inhibitor; geroprotector; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
| chlorthalidone | [no description available] | low | 0 | 0 | isoindoles; monochlorobenzenes; sulfonamide | |
| 4-chloro-N-(2,6-dimethyl-1-piperidinyl)-3-sulfamoylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| dichlorphenamide | [no description available] | low | 0 | 0 | dichlorobenzene; sulfonamide | antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor; ophthalmology drug |
| e 4031 | [no description available] | low | 0 | 0 | sulfonamide | |
| ethoxzolamide | [no description available] | low | 0 | 0 | aromatic ether; benzothiazoles; sulfonamide | antiglaucoma drug; diuretic; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| famotidine | [no description available] | low | 0 | 0 | 1,3-thiazoles; guanidines; sulfonamide | anti-ulcer drug; H2-receptor antagonist; P450 inhibitor |
| furosemide | [no description available] | low | 0 | 0 | chlorobenzoic acid; furans; sulfonamide | environmental contaminant; loop diuretic; xenobiotic |
| glimepiride | [no description available] | low | 0 | 0 | sulfonamide | |
| n-(2-(methylamino)ethyl)-5-isoquinolinesulfonamide | [no description available] | low | 0 | 0 | isoquinolines; sulfonamide | |
| N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide | [no description available] | low | 0 | 0 | bromobenzenes; isoquinolines; olefinic compound; secondary amino compound; sulfonamide | EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor |
| hydrochlorothiazide | [no description available] | low | 0 | 0 | benzothiadiazine; organochlorine compound; sulfonamide | antihypertensive agent; diuretic; environmental contaminant; xenobiotic |
| hydroxymethyltolbutamide | [no description available] | low | 0 | 0 | benzyl alcohols; sulfonamide; ureas | metabolite |
| indapamide | [no description available] | low | 0 | 0 | indoles; organochlorine compound; sulfonamide | antihypertensive agent; diuretic |
| methazolamide | [no description available] | low | 0 | 0 | sulfonamide; thiadiazoles | |
| metolazone | [no description available] | low | 0 | 0 | organochlorine compound; quinazolines; sulfonamide | antihypertensive agent; diuretic; ion transport inhibitor |
| monodansylcadaverine | [no description available] | low | 0 | 0 | aminonaphthalene; primary amino compound; sulfonamide; tertiary amino compound | EC 2.3.2.13 (protein-glutamine gamma-glutamyltransferase) inhibitor; fluorochrome; protective agent |
| n-(4-aminobutyl)-5-chloro-2-naphthalenesulfonamide | [no description available] | low | 0 | 0 | naphthalenes; organochlorine compound; primary amino compound; sulfonamide | |
| naratriptan | [no description available] | low | 0 | 0 | heteroarylpiperidine; sulfonamide; tryptamines | serotonergic agonist; vasoconstrictor agent |
| nimesulide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
| n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide | [no description available] | low | 0 | 0 | aromatic ether; C-nitro compound; sulfonamide | antineoplastic agent; cyclooxygenase 2 inhibitor |
| 5-[3-(benzenesulfonamido)phenyl]-N-hydroxypent-2-en-4-ynamide | [no description available] | low | 0 | 0 | sulfonamide | |
| phthalylsulfathiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles; dicarboxylic acid monoamide; sulfonamide antibiotic; sulfonamide | |
| probenecid | [no description available] | low | 0 | 0 | benzoic acids; sulfonamide | uricosuric drug |
| sulfadiazine | [no description available] | low | 0 | 0 | pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; antiprotozoal drug; coccidiostat; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic |
| sotalol | [no description available] | low | 0 | 0 | ethanolamines; secondary alcohol; secondary amino compound; sulfonamide | anti-arrhythmia drug; beta-adrenergic antagonist; environmental contaminant; xenobiotic |
| SU6656 | [no description available] | low | 0 | 0 | oxindoles; sulfonamide | antineoplastic agent; Aurora kinase inhibitor; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
| sulfabenzamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide antibiotic; sulfonamide | antibacterial drug; antimicrobial drug |
| sulfacytine | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| sulfadimethoxine | [no description available] | low | 0 | 0 | aromatic ether; pyrimidines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; antimicrobial agent; drug allergen; environmental contaminant; xenobiotic |
| sulfamerazine | [no description available] | low | 0 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen |
| sulfameter | [no description available] | low | 0 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antiinfective agent; leprostatic drug; renal agent |
| sulfamethazine | [no description available] | low | 0 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antibacterial drug; antiinfective agent; antimicrobial agent; carcinogenic agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; ligand; xenobiotic |
| sulfamethizole | [no description available] | low | 0 | 0 | sulfonamide antibiotic; sulfonamide; thiadiazoles | antiinfective agent; antimicrobial agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor |
| sulfamethoxazole | [no description available] | low | 0 | 0 | isoxazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial agent; antiinfective agent; antimicrobial agent; drug allergen; EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; epitope; P450 inhibitor; xenobiotic |
| sulfamethoxypyridazine | [no description available] | low | 0 | 0 | pyridazines; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor |
| sulfamonomethoxine | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| sulfanilamide | [no description available] | low | 0 | 0 | substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial agent; drug allergen; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| sulfanitran | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfaphenazole | [no description available] | low | 0 | 0 | primary amino compound; pyrazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antibacterial drug; EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor; EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor; P450 inhibitor |
| sulfapyridine | [no description available] | low | 0 | 0 | pyridines; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; dermatologic drug; drug allergen; environmental contaminant; xenobiotic |
| sulfaquinoxaline | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| sulfathiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles; substituted aniline; sulfonamide antibiotic; sulfonamide | antiinfective agent; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; xenobiotic |
| sulfisomidine | [no description available] | low | 0 | 0 | pyrimidines; sulfonamide antibiotic; sulfonamide | antiinfective agent |
| sulfisoxazole | [no description available] | low | 0 | 0 | isoxazoles; sulfonamide antibiotic; sulfonamide | antibacterial drug; drug allergen |
| sulfoxone | [no description available] | low | 0 | 0 | sulfonamide | |
| sulpiride | [no description available] | low | 0 | 0 | benzamides; N-alkylpyrrolidine; sulfonamide | antidepressant; antiemetic; antipsychotic agent; dopaminergic antagonist |
| sumatriptan | [no description available] | low | 0 | 0 | sulfonamide; tryptamines | serotonergic agonist; vasoconstrictor agent |
| delavirdine | [no description available] | low | 0 | 0 | aminopyridine; indolecarboxamide; N-acylpiperazine; sulfonamide | antiviral drug; HIV-1 reverse transcriptase inhibitor |
| zonisamide | [no description available] | low | 0 | 0 | 1,2-benzoxazoles; sulfonamide | anticonvulsant; antioxidant; central nervous system drug; protective agent; T-type calcium channel blocker |
| 4-toluenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| n-methyl-n-nitrosotoluene-p-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfachlorpyridazine | [no description available] | low | 0 | 0 | organochlorine compound; pyridazines; sulfonamide | antibacterial drug; drug allergen; EC 2.5.1.15 (dihydropteroate synthase) inhibitor |
| acetyl sulfisoxazole | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| sulfaethidole | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| carzenide | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfalene | [no description available] | low | 0 | 0 | pyrazines; sulfonamide antibiotic; sulfonamide | |
| thioproperazine | [no description available] | low | 0 | 0 | N-alkylpiperazine; N-methylpiperazine; phenothiazines; sulfonamide | phenothiazine antipsychotic drug |
| carbutamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| glymidine | [no description available] | low | 0 | 0 | diether; pyrimidines; sulfonamide | hypoglycemic agent |
| thiazosulfone | [no description available] | low | 0 | 0 | sulfonamide | |
| glybuthiazol | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| sulfanilylurea | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| metahexamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| clopamide | [no description available] | low | 0 | 0 | sulfonamide | |
| tolcyclamide | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfamoxole | [no description available] | low | 0 | 0 | oxazole; sulfonamide antibiotic; sulfonamide | antimicrobial agent; drug allergen |
| sulfaethoxypyridazine | [no description available] | low | 0 | 0 | sulfonamide | antibacterial agent |
| 4-((diethylamino)sulfonyl)benzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| dinsed | [no description available] | low | 0 | 0 | sulfonamide | |
| amidephrine | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfadoxine | [no description available] | low | 0 | 0 | pyrimidines; sulfonamide | antibacterial drug; antimalarial |
| hydroxyhexamide | [no description available] | low | 0 | 0 | sulfonamide | |
| asulam | [no description available] | low | 0 | 0 | carbamate ester; primary amino compound; substituted aniline; sulfonamide | agrochemical; EC 2.5.1.15 (dihydropteroate synthase) inhibitor; environmental contaminant; herbicide; xenobiotic |
| n-butylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | neurotoxin; plant metabolite |
| oryzalin | [no description available] | low | 0 | 0 | aromatic amine; C-nitro compound; sulfonamide; tertiary amino compound | agrochemical; antimitotic; herbicide |
| glisoxepide | [no description available] | low | 0 | 0 | sulfonamide | |
| perfluidone | [no description available] | low | 0 | 0 | sulfonamide | |
| mefluidide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-aminosulfonyl-benzoic acid methyl ester | [no description available] | low | 0 | 0 | benzoate ester; methyl ester; sulfonamide | marine xenobiotic metabolite |
| clorsulon | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| agreal | [no description available] | low | 0 | 0 | sulfonamide | |
| n-acetylsulfapyridine | [no description available] | low | 0 | 0 | sulfonamide | |
| tirofiban | [no description available] | low | 0 | 0 | L-tyrosine derivative; piperidines; sulfonamide | anticoagulant; fibrin modulating drug; platelet glycoprotein-IIb/IIIa receptor antagonist |
| n(4)-acetylsulfadiazine | [no description available] | low | 0 | 0 | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite |
| amprenavir | [no description available] | low | 0 | 0 | carbamate ester; sulfonamide; tetrahydrofuryl ester | antiviral drug; HIV protease inhibitor |
| n(4)-acetylsulfamethoxazole | [no description available] | low | 0 | 0 | isoxazoles; sulfonamide | drug metabolite; marine xenobiotic metabolite |
| glisentide | [no description available] | low | 0 | 0 | sulfonamide | |
| ebrotidine | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chlorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-amino-6-chloro-1,3-benzenedisulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N(4)-acetylsulfathiazole | [no description available] | low | 0 | 0 | 1,3-thiazoles; acetamides; sulfonamide | marine xenobiotic metabolite |
| 2-benzothiazolesulfonamide | [no description available] | low | 0 | 0 | benzothiazoles; sulfonamide | |
| brinzolamide | [no description available] | low | 0 | 0 | sulfonamide; thienothiazine | antiglaucoma drug; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| piloty's acid | [no description available] | low | 0 | 0 | sulfonamide | |
| perfluorooctanesulfonamide | [no description available] | low | 0 | 0 | perfluorinated compound; sulfonamide | persistent organic pollutant |
| uk 68798 | [no description available] | low | 0 | 0 | aromatic ether; sulfonamide; tertiary amino compound | anti-arrhythmia drug; potassium channel blocker |
| glyclopyramide | [no description available] | low | 0 | 0 | sulfonamide | |
| fluoresone | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-aminobenzenesulfonamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| 4-chloro-5-sulfamoylanthranilic acid | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| sulfluramid | [no description available] | low | 0 | 0 | sulfonamide | acaricide; environmental contaminant; insecticide; xenobiotic |
| 8-(4-tolylsulfonylamino)quinoline | [no description available] | low | 0 | 0 | sulfonamide | |
| n-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1h-1,2,4-triazol-1-yl)phenyl)methanesulfonamide | [no description available] | low | 0 | 0 | dichlorobenzene; organofluorine compound; sulfonamide; triazoles | agrochemical; EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor; herbicide |
| cloransulam-methyl | [no description available] | low | 0 | 0 | methyl ester; monochlorobenzenes; organofluorine compound; sulfonamide; triazolopyrimidines | agrochemical; EC 2.2.1.6 (acetolactate synthase) inhibitor; herbicide |
| sdds | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| n-(2,6-difluorophenyl)-5-methyl(1,2,4)-triazol(1,5-a)pyrimidine-2-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| flazasulfuron | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
| 4-methyl-N-(phenylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| bosentan anhydrous | [no description available] | low | 0 | 0 | primary alcohol; pyrimidines; sulfonamide | antihypertensive agent; endothelin receptor antagonist |
| sulfamethoxazole hydroxylamine | [no description available] | low | 0 | 0 | isoxazoles; sulfonamide | allergen; metabolite |
| gr 113808 | [no description available] | low | 0 | 0 | indolyl carboxylate ester; piperidines; sulfonamide | serotonergic antagonist |
| valdecoxib | [no description available] | low | 0 | 0 | isoxazoles; sulfonamide | antipyretic; antirheumatic drug; cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
| ym 12617 | [no description available] | low | 0 | 0 | aromatic ether; secondary amino compound; sulfonamide | |
| dansyllysine | [no description available] | low | 0 | 0 | L-lysine derivative; non-proteinogenic L-alpha-amino acid; sulfonamide | epitope |
| almotriptan | [no description available] | low | 0 | 0 | indoles; sulfonamide; tertiary amine | non-steroidal anti-inflammatory drug; serotonergic agonist; vasoconstrictor agent |
| 4-nitrososulfamethoxazole | [no description available] | low | 0 | 0 | isoxazoles; nitroso compound; sulfonamide | allergen; metabolite |
| cki 7 | [no description available] | low | 0 | 0 | isoquinolines; organochlorine compound; primary amino compound; sulfonamide | EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor |
| fosamprenavir | [no description available] | low | 0 | 0 | sulfonamide | prodrug |
| metipamide | [no description available] | low | 0 | 0 | sulfonamide | |
| jte 522 | [no description available] | low | 0 | 0 | 1,3-oxazoles; organofluorine compound; sulfonamide | cyclooxygenase 2 inhibitor |
| carboxytolbutamide | [no description available] | low | 0 | 0 | sulfonamide | |
| tevenel | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfachlorpyrazine | [no description available] | low | 0 | 0 | sulfonamide | |
| n(4)-acetylsulfadimethoxine | [no description available] | low | 0 | 0 | acetamides; pyrimidines; sulfonamide | marine xenobiotic metabolite |
| dronedarone | [no description available] | low | 0 | 0 | 1-benzofurans; aromatic ether; aromatic ketone; sulfonamide; tertiary amino compound | anti-arrhythmia drug; environmental contaminant; xenobiotic |
| darunavir | [no description available] | low | 0 | 0 | carbamate ester; furofuran; sulfonamide | antiviral drug; HIV protease inhibitor |
| cimicoxib | [no description available] | low | 0 | 0 | aromatic ether; imidazoles; organochlorine compound; organofluorine compound; sulfonamide | cyclooxygenase 2 inhibitor; non-steroidal anti-inflammatory drug |
| dabuzalgron | [no description available] | low | 0 | 0 | aromatic ether; imidazoles; monochlorobenzenes; sulfonamide | alpha-adrenergic agonist |
| n-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide | [no description available] | low | 0 | 0 | chloroindole; organochlorine compound; sulfonamide | antineoplastic agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| 3,4-Dichlorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclooctyl-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| tolpyrramide | [no description available] | low | 0 | 0 | sulfonamide | |
| acetic acid [2-[acetyl-(4-methylphenyl)sulfonylamino]phenyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(benzenesulfonyl)indole | [no description available] | low | 0 | 0 | sulfonamide | |
| tosylphenylalanyl chloromethyl ketone | [no description available] | low | 0 | 0 | alpha-chloroketone; sulfonamide | alkylating agent; serine proteinase inhibitor |
| rosuvastatin | [no description available] | low | 0 | 0 | dihydroxy monocarboxylic acid; monofluorobenzenes; pyrimidines; statin (synthetic); sulfonamide | anti-inflammatory agent; antilipemic drug; cardioprotective agent; CETP inhibitor; environmental contaminant; xenobiotic |
| bms 214662 | [no description available] | low | 0 | 0 | benzenes; benzodiazepine; imidazoles; nitrile; sulfonamide; thiophenes | antineoplastic agent; apoptosis inducer; EC 2.5.1.58 (protein farnesyltransferase) inhibitor |
| N-[4-(methanesulfonamido)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| prinomastat | [no description available] | low | 0 | 0 | aromatic ether; hydroxamic acid; pyridines; sulfonamide; thiomorpholines | antineoplastic agent; EC 3.4.24.35 (gelatinase B) inhibitor; matrix metalloproteinase inhibitor |
| glucosulfone | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[1-(benzenesulfonyl)-3-pyrrolyl]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-bromo-2,5-dimethoxyphenyl)sulfonylazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chloro-3-methoxyphenyl)sulfonylazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-[(4-methylphenyl)sulfonyl]-6-azabicyclo[3.2.1]octane | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclopentyl-4-[[4-[2-furanyl(oxo)methyl]-1-piperazinyl]sulfonyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N4-cyclohexyl-N1-ethyl-N4-(2-pyridinylmethyl)benzene-1,4-disulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[cyclohexyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-chloro-4-methoxyphenyl)sulfonyl-N-(3-pyridinyl)-3-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3-ethoxyphenyl)-1-(4-methoxyphenyl)sulfonyl-3-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]sulfonyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(2-furanylmethylthio)ethyl]-4-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[2-[1-(4-methoxyphenyl)sulfonyl-2-benzimidazolyl]ethyl]morpholine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,5-dimethoxyphenyl)sulfonyl-N-(phenylmethyl)-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[2-chloro-5-(trifluoromethyl)phenyl]sulfonylazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[4-[(5,6-dimethyl-1-benzimidazolyl)sulfonyl]phenyl]sulfonylmorpholine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(4-methoxyphenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methyl-N-(pyridin-4-ylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclopropyl-4-(2,3-dihydroindol-1-ylsulfonyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-(benzenesulfonyl)phenyl]-5-(3,4,5-trimethoxyphenyl)-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-furanylmethyl)-2-[(4-methoxyphenyl)sulfonylamino]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(diethylsulfamoyl)phenyl]-2-(2-oxo-1,3-benzothiazol-3-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[[4-(1-benzotriazolyl)-1-piperidinyl]sulfonyl]-N-cyclopentylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N,N-dimethyl-4-[[4-(5-methyl-1-benzotriazolyl)-1-piperidinyl]sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(4-methoxyphenyl)sulfonyl-N-(phenylmethyl)-1-piperazinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(4-fluorophenyl)-2-thiazolyl]-2-[(4-methylphenyl)sulfonylamino]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-{[2-(pyridin-3-yl)piperidin-1-yl]sulfonyl}phenyl)acetamide | [no description available] | low | 0 | 0 | acetamides; piperidines; pyridines; sulfonamide | |
| 3,4,5-trimethoxy-N-[2-(4-sulfamoylphenyl)ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-phenylmethoxyphenyl)methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-fluoro-3-methylphenyl)sulfonylamino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-furanylmethyl)-4-methyl-N-(phenylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(2-ethylphenoxy)-N-(4-sulfamoylphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chlorophenyl)-3-(4-sulfamoylphenyl)urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3-chloro-4-hydroxy-2,5-dimethylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,4,6-trimethyl-n-(meta-3-trifluoromethylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[(4-phenyl-2-thiazolyl)amino]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(1-cyclohexenyl)ethyl]-2,5-dimethoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1-ethyl-5-benzimidazolyl)-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methyl-N-(5,6,7,8-tetrahydronaphthalen-1-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-N-(4-hydrazinyl-6-methyl-2-pyrimidinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-amino-N-(4-ethoxyphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| 1-(2-nitrophenyl)sulfonylpiperidine | [no description available] | low | 0 | 0 | sulfonamide | |
| N,4-dimethyl-N-(4-methylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,3,4-trimethyl-N-(3-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[4-(1-pyrrolidinylsulfonyl)phenyl]hydrazinylidene]propanedinitrile | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-(benzenesulfonyl)-2,2-dichloroethenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(4-fluoro-N-methylsulfonylanilino)-N-(3-methylphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-3-ethoxy-N-(4-ethylphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-chlorophenyl)sulfonylpyrrolidine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-cyclopropyl-3-(4-sulfamoylphenyl)thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-[methyl(methylsulfonyl)amino]phenyl]-2-phenoxyacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[methyl(methylsulfonyl)amino]-N-(2-phenylethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(2,6-dichloroanilino)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
| 4-(4-chloroanilino)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
| 1-ethyl-3-(4-methylphenyl)sulfonylthiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-chloro-N-(2-hydroxyphenyl)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
| 5-chloro-2-methoxy-N,N,4-trimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(2,5-dimethoxyphenyl)sulfonyl-methylamino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-ethylphenyl)-2-methoxy-5-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-ethoxy-N-(4-fluorophenyl)-2,3-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(1-cyclohexenyl)ethyl]-4-[methyl(methylsulfonyl)amino]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,5-dimethoxyphenyl)sulfonyl-4-ethylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(methylthio)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-methoxyphenyl)-4-(methylthio)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-methoxy-5-propan-2-yl-N-(2-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,3,5,6-tetramethyl-N-(2-methyl-1,3-benzothiazol-5-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-chloro-2-methyl-5-(2-pyridinylsulfamoyl)phenoxy]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3-chlorophenyl)-N-[2-(3,4-dihydro-1H-isoquinolin-2-yl)-2-oxoethyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(6-methyl-1,3-benzothiazol-2-yl)phenyl]-2-(3-methyl-N-methylsulfonylanilino)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-bromo-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(2,6-dimethoxy-4-pyrimidinyl)sulfamoyl]phenyl]butanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(3-pyridinyl)-4-[4-(1-pyrrolidinylsulfonyl)phenyl]thiazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-bromo-6-chloro-N-(4-methyl-2-pyridinyl)-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
| 4-(4-fluorophenyl)sulfonyl-2-(2-furanyl)-N-phenyl-5-oxazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[4-(4-methylphenyl)sulfonyl-1-piperazinyl]methyl]-4-propan-2-ylphenol | [no description available] | low | 0 | 0 | sulfonamide | |
| ethyl 4-{N-[(4-chlorophenyl)sulfonyl]-N-methylglycyl}piperazine-1-carboxylate | [no description available] | low | 0 | 0 | carbamate ester; sulfonamide | |
| N-[(2-chlorophenyl)methyl]-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[methyl-(2,4,6-trimethylphenyl)sulfonylamino]-N-(2-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-ethoxyphenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chlorophenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(1-piperidinylsulfonyl)phenyl]-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1,3-benzothiazol-2-yl)-2-[methyl-(4-methylphenyl)sulfonylamino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-cyclohexyl-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(5-chloro-2-hydroxyphenyl)-1,3-dimethyl-2-oxo-5-benzimidazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,5-dichloro-4-ethoxy-N-(2-pyridinylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-ethoxy-2,3,5-trimethyl-N-(3-pyridinylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(3,4-dimethoxyphenyl)sulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-3-(1-piperidinylsulfonyl)-N-(2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[N-(benzenesulfonyl)-4-ethoxyanilino]-N-(2-methoxyphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,5-dimethoxyphenyl)sulfonyl-4-(phenylmethyl)piperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[(4-chlorophenyl)methyl-methylsulfonylamino]-N-(2-pyridinylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-bromo-2-methoxy-N-(3-methyl-2-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| pyrabactin | [no description available] | low | 0 | 0 | naphthalenes; organobromine compound; pyridines; sulfonamide | abscisic acid receptor agonist; hormone; plant growth regulator |
| 2-(4-methoxyphenyl)-N-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1,4-bis[(4-methoxy-2-methylphenyl)sulfonyl]-1,4-diazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-furanylmethyl)-4-(1-pyrrolidinylsulfonyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(benzenesulfonyl)-N-methyl-N-phenyl-1-piperazinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(3-ethylphenoxy)-N-[4-(2-pyridinylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[1-(benzenesulfonyl)-4-piperidinyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(1,3-benzodioxol-5-yl)-3-[4-[(5-methyl-3-isoxazolyl)sulfamoyl]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(1,3-benzodioxol-5-yl)-3-[4-[(phenylmethyl)sulfamoyl]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| 1,3-diethyl-6-methyl-N-(2-methylphenyl)-2-oxo-5-benzimidazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1,3-benzodioxol-5-ylmethyl)-4-methyl-3-(1-piperidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(1-azepanylsulfonyl)-N-(3-isoxazolyl)-4-methylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-methylsulfonyl-N-(6,7,8,9-tetrahydrodibenzofuran-2-yl)-2,3-dihydroindole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[2-chloro-4-(2,3-dihydroindol-1-ylsulfonyl)phenoxy]-N-(2-pyridinylmethyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-bromo-3-ethoxyphenyl)sulfonyl-3,5-dimethylpyrazole | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-hydroxy-3,5-dimethylphenyl)-2,5-dimethyl-3-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-[(5-tert-butyl-2,3-dimethylphenyl)sulfonylamino]-2-hydroxybenzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chloro-2,5-dimethoxyphenyl)sulfonylbenzotriazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-chloro-5-(cyclopentylsulfamoyl)-2-methylphenoxy]-N-cyclohexylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(1,3-benzothiazol-2-ylthio)-N-(4-methylphenyl)sulfonylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,4-dichloro-5-(diethylsulfamoyl)-N-(1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cycloheptyl-1-(4-methylphenyl)sulfonyl-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-methyl-1,3-benzothiazol-6-yl)-4-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(dimethylsulfamoyl)-N-(4-thiophen-2-yl-2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[1-(4-tert-butylphenyl)sulfonyl-4-piperidinyl]-6-chloro-1H-benzimidazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[5-(1H-benzimidazol-2-yl)-2-pyridinyl]thio]-N-[4-(1-pyrrolidinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[[3-[(2-chlorophenyl)methyl]-5-cyclopropyl-7-triazolo[4,5-d]pyrimidinyl]amino]-N,N-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 7-methyl-2-[4-(4-methylphenyl)sulfonyl-1,4-diazepan-1-yl]-3-quinolinecarbonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-amino-5-(benzenesulfonyl)-2-methoxy-3-pyridinecarbonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-amino-5-(4-chlorophenyl)sulfonyl-2-oxo-1H-pyridine-3-carbonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[benzenesulfonyl(2-pyridinyl)amino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-chlorophenyl)sulfonyl-(2-pyridinyl)amino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,5-dichloro-N-(1,5,6-trimethyl-4-benzimidazolyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-fluorophenyl)sulfonyl-(2-pyridinyl)amino]-N-phenylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-[1-(benzenesulfonyl)-3-pyrazolyl]-2-phenylthiazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-[1-(4-fluorophenyl)sulfonyl-3-pyrazolyl]-2-phenylthiazole | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-[(3,4-dichlorophenyl)methyl]-6-oxo-3-pyridinyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(benzenesulfonylmethyl)-5-(4-chlorophenyl)cyclohexane-1,3-dione | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(benzenesulfonyl)-3-pyrazolidinone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-methyl-4-pyrazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-methoxyphenyl)-2-(3-methylphenoxy)-N-(4-methylphenyl)sulfonylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(4-fluorophenyl)-2-thiazolyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[[4-(diethylsulfamoyl)phenyl]-oxomethyl]amino]-4-methyl-5-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| tosylarginine methyl ester | [no description available] | low | 0 | 0 | guanidines; L-arginine ester; methyl ester; sulfonamide | |
| n-(4-(n-(3-methoxypyrazin-2-yl)sulfamoyl)phenyl)-3-(5-nitrothiophene-2-yl)acrylamide | [no description available] | low | 0 | 0 | pyrazines; sulfonamide; thiophenes | necroptosis inhibitor; neuroprotective agent |
| N-[(benzenesulfonylhydrazo)-sulfanylidenemethyl]-4-methylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| xl147 | [no description available] | low | 0 | 0 | aromatic amine; benzothiadiazole; quinoxaline derivative; sulfonamide | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor |
| 7-chloro-2-methyl-4-(4-methylphenyl)sulfonylthiazolo[5,4-b]indole | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(4-methyl-1-piperidinyl)sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[methyl-(phenylmethyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(4-bromophenyl)sulfonyl-2-(2-furanyl)-5-(methylthio)oxazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(4-morpholinylsulfonyl)-N-(5-thiophen-2-yl-1,3,4-oxadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-fluorophenyl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methoxy-N-(3-methylbutyl)-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1,3-benzothiazol-2-yl)-3-(2,3-dihydroindol-1-ylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1H-benzimidazol-2-yl)-3-[phenyl(prop-2-enyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-2-[(5,7-dimethyl-[1,2,4]triazolo[4,3-a]pyrimidin-3-yl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[4-(4-morpholinylsulfonyl)phenyl]propanoic acid [2-[(5-chloro-2-pyridinyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-chloro-2-thiophenyl)sulfonylamino]-N-(2-furanylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,5-difluoro-N-[2-(4-morpholinylmethyl)-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-(ethylthio)-1,3,4-thiadiazol-2-yl]-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-methyl-1,3-benzothiazol-6-yl)-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(4-acetyl-1-piperazinyl)sulfonyl]-N-(1H-benzimidazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(3-hydroxy-5-benzotriazolyl)sulfonylamino]benzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(5-chloro-2,4-dimethoxyphenyl)-methylsulfamoyl]-N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(2-fluorophenoxy)-N-[4-(2-furanylmethylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[[[5-[3-(1-piperidinylsulfonyl)phenyl]-1,3,4-oxadiazol-2-yl]thio]methyl]-1,2,3-benzotriazin-4-one | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1H-benzimidazol-2-yl)-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,6-dichloro-N-[2-(methylthio)-1,3-benzothiazol-6-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-fluoro-3-methoxy-N-(2-pyridinyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(5-ethyl-1,3,4-oxadiazol-2-yl)-4-[methyl(phenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[bis(2-methoxyethyl)sulfamoyl]-N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(dipropylsulfamoyl)-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[butyl(methyl)sulfamoyl]-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[ethyl-(phenylmethyl)sulfamoyl]-N-(5-methyl-1,3,4-oxadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[ethyl-(phenylmethyl)sulfamoyl]-N-[5-(2-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[bis(2-methylpropyl)sulfamoyl]-N-[5-(3-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-methyl-2-thiazolyl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-(2-methylpropyl)-1,3,4-thiadiazol-2-yl]-4-nitrobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-butyl-1H-1,2,4-triazol-3-yl)thio]-N-(4-sulfamoylphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-ethoxy-N-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(dibutylsulfamoyl)phenyl]-2-thiophen-2-ylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,3-dichloro-4-methoxy-N-(3-methoxypropyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(3-cyano-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-2-yl)thio]-N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-furanylmethyl)-2-[4-(propylsulfamoyl)phenoxy]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(benzenesulfonamido)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methyl-N-[2-(phenylmethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-chloro-5-(cyclohexylsulfamoyl)-2-methylphenoxy]-N-(1,3,4-thiadiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(cyclohexylthio)ethyl]-4-methyl-3-[(4-methylphenyl)sulfamoyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-chlorophenyl)-3-[3-[methyl(methylsulfonyl)amino]phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(cyanomethyl)phenyl]-4-cyclohexylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-ethoxyphenyl)-4-[[4-(methylthio)phenyl]sulfonylamino]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(methanesulfonamido)-N-[2-(phenylmethylthio)ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-fluorophenyl)-4-methoxy-2,5-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[benzenesulfonyl-(phenylmethyl)amino]-N-ethylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[benzenesulfonyl(methyl)amino]-N-[2-[(4-chlorophenyl)methylthio]ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3,4-dimethyl-2-sulfanylidene-5-thiazolyl)carbamic acid 2-[(2,5-dimethylphenyl)sulfonylamino]ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[cyclohexyl-(4-methylphenyl)sulfonylamino]-N-(3-methoxypropyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(4-sulfamoylphenyl)sulfamoyl]phenyl]cyclopropanecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1H-benzimidazol-2-yl)-4-(dimethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-chlorophenyl)-3-[2-(thiophen-2-ylsulfonylamino)phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-methyl-3-(1-piperidinylsulfonyl)phenyl]-1,2-benzothiazol-3-one | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1H-benzimidazol-2-ylmethyl)-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-fluoro-2-methylphenyl)sulfonylamino]-N-(3-pyridinylmethyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-cyanophenyl)methylthio]-N-(2-methoxyphenyl)-1,3-benzoxazole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[4-(4-morpholinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(1-azepanylsulfonyl)-4-chloro-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| sr 3335 | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1H-benzimidazol-2-ylmethyl)-4-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-chlorophenyl)methylthio]-5-[3-(1-piperidinylsulfonyl)phenyl]-1,3,4-oxadiazole | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-3-[(4-chlorophenyl)sulfamoyl]-N-(1H-1,2,4-triazol-5-yl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2-fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(4-methyl-1-piperazinyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2-methoxyphenyl)-2-(2-oxopropylthio)-1,3-benzoxazole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[5-(1-pyrrolidinylsulfonyl)-2-thiophenyl]-N-[2-(4-sulfamoylphenyl)ethyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-fluorophenyl)-1-cyclopentanecarboxylic acid [2-oxo-2-(4-sulfamoylanilino)ethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(2-chlorophenyl)sulfonylpropanoic acid [2-[(3,5-dichloro-6-methyl-2-pyridinyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-[benzenesulfonyl(methyl)amino]phenoxy]-N-(1,3-benzothiazol-2-yl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(6-methoxy-1,3-benzothiazol-2-yl)-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclopentyl-3,4-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-amino-1-(2-methoxyethyl)-N-(4-methylphenyl)sulfonyl-2,4-dioxo-5-pyrimidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(benzenesulfonyl)propanoic acid [2-[(3,5-dichloro-4-methyl-2-pyridinyl)amino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[2-cyanoethyl(methyl)amino]-sulfanylidenemethyl]-4-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| [4-methoxy-3-(4-morpholinylsulfonyl)phenyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| [4-(4-bromo-2-chlorophenyl)sulfonyl-1-piperazinyl]-(2-sulfanylidene-1H-pyridin-3-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| [1-(4-fluorophenyl)sulfonyl-4-piperidinyl]-(4-phenyl-3,6-dihydro-2H-pyridin-1-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(1S)-1-(1H-benzimidazol-2-yl)-2-methylpropyl]-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(3-chloro-2,4,6-trifluorophenyl)sulfonyl-1-piperazinyl]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(4-methoxyphenyl)-N-[4-(2-pyrimidinylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N1-[4-(aminosulfonyl)phenyl]-2,2-dimethylpropanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(benzenesulfonylmethyl)-5-(4-methoxyphenyl)cyclohexane-1,3-dione | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[bis(2-methylpropoxy)phosphoryl]-3,3,3-trifluoro-2-[(4-methylphenyl)sulfonylamino]propanoic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| N1-{3-[2-(2-pyridyl)ethyl]phenyl}-4-chlorobenzene-1-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| ethyl 1-[4-(4-chlorobenzenesulfonamido)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate | [no description available] | low | 0 | 0 | ethyl ester; monochlorobenzenes; organofluorine compound; pyrazoles; sulfonamide | |
| 2,3-dichloro-N'-[4-(trifluoromethyl)-2-pyrimidinyl]benzenesulfonohydrazide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-ethyl-2-pyridinyl)-3-(4-methylphenyl)sulfonylurea | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3,5-dimethylphenyl)-3-[5-(dimethylsulfamoyl)-2-methylphenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-{5-[(dimethylamino)sulfonyl]-2-methylphenyl}cyclohexanecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-tert-butyl-3-[(4-methylphenyl)sulfonylamino]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-methylphenyl)sulfonylamino]pentanoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-methyl-4,7-bis(methylsulfonyl)-3a,5,6,7a-tetrahydro-1H-imidazo[4,5-b]pyrazin-2-one | [no description available] | low | 0 | 0 | imidazopyrazine; sulfonamide; ureas | |
| N-(3-acetyl-2-methyl-5-benzofuranyl)-N-(4-chloro-3-nitrophenyl)sulfonylacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(4-chlorophenyl)thio]-N-[4-[(2,4-dimethylphenyl)sulfamoyl]phenyl]propanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-N-[2-(4-morpholinyl)cyclohexyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(n,n-dimethylsulfonamido)-4-methyl-nitrobenzene | [no description available] | low | 0 | 0 | C-nitro compound; sulfonamide; toluenes | bone density conservation agent; EC 3.1.4.53 (3',5'-cyclic-AMP phosphodiesterase) inhibitor; geroprotector |
| [4-(benzenesulfonyl)-1-piperazinyl]-(1-piperidinyl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-(2-furanyl)-3-phenylpropyl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-(butylsulfamoyl)phenyl]-2-phenyl-2-(phenylthio)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2,6-dimethyl-3-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-N,4-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[4-(1-adamantyl)-N-methylsulfonylanilino]acetic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[4-(1-pyrrolidinylsulfonyl)phenyl]-2-thiazolyl]-2,3-dihydro-1,4-benzodioxin-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(5-(4-methoxyphenyl)-3-phenyl-4,5-dihydro-1h-pyrazol-1-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[oxo-[1-(2,4,6-trimethylphenyl)sulfonyl-4-piperidinyl]methyl]-1-piperazinecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| N,4-dimethyl-N-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(1-phenylethyl)-3,4-dihydro-1H-pyrazino[1,2-a]benzimidazol-8-yl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-(4-chlorophenyl)sulfonyl-2-pyrrolidinyl]-4-methyl-1-piperazinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-(benzenesulfonyl)-1-piperazinyl]-2-[[1-(2-methylpropyl)-2-benzimidazolyl]thio]ethanone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(4-hydroxyphenyl)-methylsulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-N-ethyl-N-phenyl-3-pyridinesulfonamide | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
| 4-chloro-N-(1-propyl-2-benzimidazolyl)-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,3-dihydro-1,4-benzodioxin-3-yl-[4-(3,4-dimethylphenyl)sulfonyl-1-piperazinyl]methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1-propyl-2-benzimidazolyl)-3-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(benzenesulfonyl)-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-nitrophenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| sulfatolamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| e 7010 | [no description available] | low | 0 | 0 | sulfonamide | |
| deracoxib | [no description available] | low | 0 | 0 | organofluorine compound; pyrazoles; sulfonamide | cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
| diclosulam | [no description available] | low | 0 | 0 | sulfonamide | |
| benzene-1-3-disulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-[(2-chloro-1-oxopropyl)hydrazo]-2-oxoethyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-nitro-N-(pyridin-4-ylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[2-[(4-acetamidophenyl)sulfonylamino]-4-thiazolyl]acetic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[3-(benzenesulfonyl)-2-(1-piperidinyl)propyl]piperidine | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-(2-furanyl)-4-[4-(methanesulfonamido)phenyl]-2-oxo-1-cyclohex-3-enecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-(benzenesulfonyl)-N-[5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl]propanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2-furanylmethyl)-3-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| N1-butan-2-yl-N4-[2-(3,4-dimethoxyphenyl)ethyl]-N4-(thiophen-2-ylmethyl)benzene-1,4-disulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chlorophenyl)sulfonyl-N'-[oxo-[4-(1-piperidinylsulfonyl)phenyl]methyl]-4-piperidinecarbohydrazide | [no description available] | low | 0 | 0 | sulfonamide | |
| N,N-dimethyl-4-[[3-[3-(5-methyl-2-furanyl)-1,2,4-oxadiazol-5-yl]-1-piperidinyl]sulfonyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-methylphenyl)sulfonyl-3-methylsulfonylimidazolidine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-bromophenyl)sulfonyl-4-[(3-methoxyphenyl)methyl]-1,4-diazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]imino-3,4-dimethyl-5-thiazolecarboxylic acid ethyl ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-chlorophenyl)sulfonyl-N-(2-thiazolyl)-1-cyclopropanecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-methyl-N-[4-(trifluoromethyl)phenyl]-4-imidazolesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(2,3-dihydro-1,4-benzodioxin-6-yl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methylanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N,N-diethyl-4-[[5-oxo-6-(phenylmethyl)-7H-pyrrolo[3,4-b]pyridin-7-yl]amino]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1,3-benzodioxol-5-yl)-5-bromo-1-[cyclopropyl(oxo)methyl]-N-ethyl-2,3-dihydroindole-7-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3,4-dimethylphenyl)-2-[N-[(3,5-dimethyl-1H-pyrazol-4-yl)sulfonyl]-4-methoxyanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3,4-dimethoxy-N-[3-(methylthio)phenyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(3,4-dimethoxyphenyl)ethyl]-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-methylanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| cyclopentanecarboxylic acid [4-(benzenesulfonyl)-2-tert-butyl-5-methyl-3-pyrazolyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[[(4-acetamidophenyl)sulfonylamino]methyl]-N-(3-methoxypropyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methyl-N-[2,4,6-trioxo-1-phenyl-5-(trifluoromethyl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-ethyl-2-[[[4-(4-morpholinylsulfonyl)phenyl]-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(2,3-dihydro-1,4-benzodioxin-3-ylmethylamino)-3-nitrobenzenesulfonamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| 4-[[(4-methylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-chloro-1,3-benzothiazol-2-yl)thio]-N-[3-(4-morpholinylsulfonyl)phenyl]propanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(6-ethoxy-1,3-benzothiazol-2-yl)-4-methoxy-3-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-ethoxy-3-pyridinecarboxylic acid [2-[2-methyl-5-(4-morpholinylsulfonyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[2-(2-ethyl-1-oxobutyl)-3-phenyl-3,4-dihydropyrazol-5-yl]phenyl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-[(2-chlorophenyl)sulfamoyl]-4-methoxyphenyl]-4-oxo-4-thiophen-2-ylbutanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(4-methyl-N-(4-methylphenyl)sulfonylanilino)-N-[(1-methyl-4-piperidinylidene)amino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| fh535 | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-chloro-3-[(2-methoxyphenyl)sulfamoyl]phenyl]-3-(2-methoxyphenyl)urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(3,4-dimethyl-5-isoxazolyl)sulfamoyl]phenyl]-2-(2-pyrimidinylthio)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[[5-(dimethylsulfamoyl)-2-methylanilino]-sulfanylidenemethyl]hydrazo]-2-oxoacetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-butylphenyl)-3-[4-chloro-3-(dimethylsulfamoyl)phenyl]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-methyl-2-[[oxo-[4-(1-pyrrolidinylsulfonyl)phenyl]methyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(1,3-benzothiazol-2-ylthio)-N-[2-hydroxy-5-(4-morpholinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-butyl-4,6-dimethyl-3-(2-methylphenyl)sulfonyl-2-pyridinone | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(4-methylphenyl)sulfonyl-3-phenyl-2,3-dihydro-1,4-benzoxazine | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-(4-methyl-1-piperazinyl)-1,4-dioxo-2-naphthalenyl]benzenesulfonamide | [no description available] | low | 0 | 0 | 1,4-naphthoquinones; piperazines; sulfonamide | |
| N-(2,2,4-trimethyl-3H-benzofuran-7-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-furanyl-[4-(4-propan-2-ylphenyl)sulfonyl-1-piperazinyl]methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-amino-2-(diethylamino)-N-(2-methoxyphenyl)benzenesulfonamide | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| N-(1,3-dimethyl-2-oxo-5-benzimidazolyl)-4-fluoro-3-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-(diethylsulfamoyl)-2-methoxyphenyl]-2-[(2,5-dimethylphenyl)thio]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-anilino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(1-piperidinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-[3-(1-imidazolyl)propyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[3-(3-oxo-1,2-benzothiazol-2-yl)phenyl]sulfonylamino]benzoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(1,2-dimethyl-5-indolyl)methyl]-4-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N,6-dimethyl-2-[[[4-[(2-methyl-1-piperidinyl)sulfonyl]phenyl]-oxomethyl]amino]-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclopropyl-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-(1H-benzimidazol-2-yl)ethyl]-3-(dimethylsulfamoyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[(3-methyl-1-piperidinyl)sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(1,2-dimethyl-5-indolyl)methylsulfamoyl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,3-dihydro-1,4-benzodioxin-3-carboxylic acid [2-[2-methyl-5-(4-morpholinylsulfonyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[5-(4-methylanilino)-1,3,4-thiadiazol-2-yl]thio]-N-[3-(3,4,5,6-tetrahydro-2H-azepin-7-ylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(1,3-benzothiazol-2-ylthio)-N-[2-chloro-5-(4-morpholinylsulfonyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[3-(dimethylsulfamoyl)phenyl]-3-(2-furanylmethyl)thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-nitro-2-furancarboxylic acid [2-oxo-2-[3-(1-piperidinylsulfonyl)anilino]ethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-(4-methoxyphenyl)ethyl]-2-nitro-4-(1-pyrrolidinylsulfonyl)aniline | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| N-(2-ethoxyphenyl)-2,1,3-benzothiadiazole-4-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-[2-(4-fluorophenyl)sulfonyl-3-thiophen-2-yl-3,4-dihydropyrazol-5-yl]phenyl]ethanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-[(2-methyl-1-piperidinyl)sulfonyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(3,5-dimethyl-1-piperidinyl)-sulfanylidenemethyl]-2-methyl-5-(4-morpholinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[bis(2-methoxyethyl)sulfamoyl]-N-[5-(methoxymethyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(benzenesulfonamido)-6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid propan-2-yl ester | [no description available] | low | 0 | 0 | isopropyl ester; sulfonamide | |
| 2-(3,4-dichlorophenyl)-N-[3-(dimethylsulfamoyl)-4-methylphenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-Cyclopentyl-2-(N-methyl3-chlorobenzenesulfonamido)acetamide | [no description available] | low | 0 | 0 | sulfonamide | anticoronaviral agent |
| N-[5-(1-azepanylsulfonyl)-2-chlorophenyl]-2-[(4-methyl-1,2,4-triazol-3-yl)thio]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(4-methoxyphenyl)-3-[3-(1-piperidinylsulfonyl)phenyl]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[2-(trifluoromethyl)phenyl]sulfonyl-4-piperidinecarboxylic acid [2-[(4-fluorophenyl)methylamino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 6-methyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid [2-[4-methyl-3-(1-piperidinylsulfonyl)anilino]-2-oxoethyl] ester | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[4-(4-butan-2-ylphenyl)sulfonyl-1-piperazinyl]butanoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(2,6-dimethyl-4-morpholinyl)sulfonyl]-N-(5-methyl-2-thiazolyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[4-(2-methoxyphenyl)sulfonyl-1-piperazinyl]sulfonyl]benzonitrile | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[(5-amino-1,3,4-thiadiazol-2-yl)thio]-N-[3-(diethylsulfamoyl)phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[(4-methyl-1-piperazinyl)sulfonyl]-N-(4-phenyl-2-thiazolyl)-N-prop-2-enylbenzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(7-methyloctyl)-3-[4-(4-morpholinylsulfonyl)phenyl]thiourea | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-[(5-bromo-2-ethoxyphenyl)sulfonylamino]-2-chloro-N,N-dimethylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[5-[(4-fluorophenoxy)methyl]-4-prop-2-enyl-1,2,4-triazol-3-yl]thio]-N-(3-sulfamoylphenyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N,N-dimethyl-3-(3-oxo-1,2-benzothiazol-2-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]-4-(1-pyrrolidinylsulfonyl)benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(dimethylsulfamoyl)-N-[5-(2-furanyl)-1,3,4-oxadiazol-2-yl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-methyl-2-[[[4-[methyl(phenyl)sulfamoyl]phenyl]-oxomethyl]amino]-6-propyl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[4-chloro-3-(4-morpholinylsulfonyl)phenyl]-3-phenylurea | [no description available] | low | 0 | 0 | sulfonamide | |
| dorzolamide | [no description available] | low | 0 | 0 | sulfonamide; thiophenes | antiglaucoma drug; antihypertensive agent; EC 4.2.1.1 (carbonic anhydrase) inhibitor |
| 3-(4-methylphenyl)sulfonyl-3-azabicyclo[2.2.1]hept-5-ene-2-carboxylic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(3,4-difluorophenyl)-2-[N-[(3,5-dimethyl-4-isoxazolyl)sulfonyl]-4-ethoxyanilino]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-[(4-methoxyphenyl)sulfonylmethyl]-N-(3-methoxypropyl)-2-furancarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-cyclohexyl-N-ethyl-1,3-dimethyl-2,4-dioxo-5-pyrimidinesulfonamide | [no description available] | low | 0 | 0 | pyrimidone; sulfonamide | |
| 1,3-dimethyl-2,4-dioxo-N-(4-propan-2-ylphenyl)-5-pyrimidinesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2,5-dimethoxy-N-[[2-(4-methoxyphenyl)-4-thiazolyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| kn 93 | [no description available] | low | 0 | 0 | monochlorobenzenes; monomethoxybenzene; primary alcohol; sulfonamide; tertiary amino compound | EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor; geroprotector |
| ro 4-6790 | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| jnj-7706621 | [no description available] | low | 0 | 0 | sulfonamide | |
| sultan | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[2-furanyl(oxo)methyl]-N-[4-[(3-methyl-1-piperidinyl)sulfonyl]phenyl]-4-piperidinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| sb 269970 | [no description available] | low | 0 | 0 | sulfonamide | |
| belinostat | [no description available] | low | 0 | 0 | hydroxamic acid; olefinic compound; sulfonamide | antineoplastic agent; EC 3.5.1.98 (histone deacetylase) inhibitor |
| 2-bromo-N-(phenylmethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-(2,5-dichlorophenyl)sulfonyl-N-methyl-N-[(2-methylphenyl)methyl]ethanamine | [no description available] | low | 0 | 0 | sulfonamide | |
| ((3z)-n-(3-chlorophenyl)-3-((3,5-dimethyl-4-((4-methylpiperazin-1-yl)carbonyl)-1h-pyrrol-2-yl)methylene)-n-methyl-2-oxo-2,3-dihydro-1h-indole-5-sulfonamide) | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-methyl-5-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 5-chloro-N-[4-(2-thiazolo[5,4-b]pyridinyl)phenyl]-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-methyl-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-(5-(4-fluorophenyl)-3-(trifluoromethyl)-1h-pyrazol-1-yl)benzenesulfonamide | [no description available] | low | 0 | 0 | organofluorine compound; pyrazoles; sulfonamide | cyclooxygenase 2 inhibitor; non-narcotic analgesic; non-steroidal anti-inflammatory drug |
| bm 567 | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| mre 269 | [no description available] | low | 0 | 0 | aromatic amine; ether; monocarboxylic acid; pyrazines; sulfonamide; tertiary amino compound | drug metabolite; orphan drug; platelet aggregation inhibitor; prostacyclin receptor agonist; vasodilator agent |
| pazopanib | [no description available] | low | 0 | 0 | aminopyrimidine; indazoles; sulfonamide | angiogenesis modulating agent; antineoplastic agent; tyrosine kinase inhibitor; vascular endothelial growth factor receptor antagonist |
| azd2858 | [no description available] | low | 0 | 0 | aromatic amine; N-methylpiperazine; pyrazines; pyridines; secondary carboxamide; sulfonamide | antineoplastic agent; bone density conservation agent; EC 2.7.11.26 (tau-protein kinase) inhibitor; Wnt signalling activator |
| 4-(2-((1r)-1-(((4-chlorophenyl)sulfonyl)-2,5-difluoroanilino)ethyl)-5-fluorophenyl)butanoic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| apratastat | [no description available] | low | 0 | 0 | sulfonamide | |
| N-methyl-N-[2-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| florasulam | [no description available] | low | 0 | 0 | sulfonamide | |
| (1S,2R)-2-[[4-[(2,4-dimethylphenyl)sulfamoyl]anilino]-oxomethyl]-1-cyclohexanecarboxylic acid | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[1-(4-bromophenyl)sulfonyl-3,6-dihydro-2H-pyridin-4-yl]-1,2-dimethylindole | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[3-(3-fluorophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 2-[[[4-[(2,6-dimethyl-4-morpholinyl)sulfonyl]phenyl]-oxomethyl]amino]-3-thiophenecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[3-(4-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-[ethyl(phenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| calcium crimson | [no description available] | low | 0 | 0 | ammonium betaine; sulfonamide | fluorochrome |
| 4-methoxy-N-[[1-[(3-methyl-2-thiophenyl)-oxomethyl]-3-piperidinyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N'-[[3-(4-methylphenyl)sulfonyl-2-oxazolidinyl]methyl]-N-[2-(4-sulfamoylphenyl)ethyl]oxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| tg101209 | [no description available] | low | 0 | 0 | N-alkylpiperazine; N-arylpiperazine; pyrimidines; secondary amino compound; sulfonamide | antineoplastic agent; apoptosis inducer; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor |
| fedratinib | [no description available] | low | 0 | 0 | sulfonamide | |
| WAY-316606 | [no description available] | low | 0 | 0 | (trifluoromethyl)benzenes; piperidines; secondary amino compound; sulfonamide; sulfone | secreted frizzled-related protein 1 inhibitor |
| azd5438 | [no description available] | low | 0 | 0 | sulfonamide | |
| gdc 0941 | [no description available] | low | 0 | 0 | indazoles; morpholines; piperazines; sulfonamide; thienopyrimidine | EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor |
| 4-methoxy-N-[[4-[oxo-[4-(phenylmethyl)-1-piperazinyl]methyl]phenyl]methyl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-[methyl-(3-methylphenyl)sulfamoyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| gsk 1016790a | [no description available] | low | 0 | 0 | 1-benzothiophenes; aromatic primary alcohol; dichlorobenzene; N-acylpiperazine; sulfonamide; tertiary carboxamide | TRPV4 agonist |
| plx 4720 | [no description available] | low | 0 | 0 | aromatic ketone; difluorobenzene; organochlorine compound; pyrrolopyridine; sulfonamide | antineoplastic agent; B-Raf inhibitor |
| gsk 2126458 | [no description available] | low | 0 | 0 | aromatic ether; difluorobenzene; pyridazines; pyridines; quinolines; sulfonamide | anticoronaviral agent; antineoplastic agent; autophagy inducer; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor; radiosensitizing agent |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(4-fluorophenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| (2R)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| [4-(2,6-difluorophenyl)sulfonyl-1-piperazinyl]-(2,3-dihydro-1,4-benzodioxin-6-yl)methanone | [no description available] | low | 0 | 0 | sulfonamide | |
| (2R)-1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| (2S)-4-(2,6-difluorophenyl)sulfonyl-1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| (2S)-1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2-methylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-pyridinylsulfonyl)piperazine | [no description available] | low | 0 | 0 | pyridines; sulfonamide | |
| N-[1-(2,6-difluorophenyl)sulfonyl-4-piperidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,6-difluorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepane | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[3-(trifluoromethyl)phenyl]sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-azetidinyl]methyl]-2,6-difluorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[1-(2,6-difluorophenyl)sulfonyl-3-azetidinyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-3-pyrrolidinyl]-2,6-difluorobenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[3-[(2,6-difluorophenyl)sulfonylamino]propyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[5-[(2,6-difluorophenyl)sulfonylamino]pentyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[6-[(2,6-difluorophenyl)sulfonylamino]hexyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-[(2,6-difluorophenyl)sulfonylamino]ethyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[1-(2,6-difluorophenyl)sulfonyl-3-pyrrolidinyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[(2,6-difluorophenyl)sulfonylamino]butyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2-nitrophenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[4-(4-methylphenyl)sulfonyl-1-piperazinyl]-2-thiophen-2-ylquinazoline | [no description available] | low | 0 | 0 | sulfonamide | |
| plx4032 | [no description available] | low | 0 | 0 | aromatic ketone; difluorobenzene; monochlorobenzenes; pyrrolopyridine; sulfonamide | antineoplastic agent; B-Raf inhibitor |
| N-[[4-[(2,6-difluorophenyl)sulfonylamino]cyclohexyl]methyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-chlorophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(3-bromophenyl)sulfonyl-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| (1S,4S)-2-(2,6-difluorophenyl)sulfonyl-5-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-2,5-diazabicyclo[2.2.1]heptane | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-(2,4,6-trifluorophenyl)sulfonylpiperazine | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1-cyano-3-pyrrolidinyl)-3-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1-cyano-3-pyrrolidinyl)-4-(trifluoromethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(1-cyano-4-piperidinyl)-4-(trifluoromethyl)benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[3-(3-methylphenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-[3-(3-bromophenyl)-5-phenyl-3,4-dihydropyrazol-2-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-cyclohexyl-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)sulfonyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-2-[[(3,4-dichlorophenyl)methyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-2-thiophenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[[(2S,3S)-10-(dimethylamino)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-4-methoxy-N-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2R,3S)-2-[[(4-chlorophenyl)sulfonyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4,4,4-trifluorobutanamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-cyclohexyl-1-[[(2S,3S)-8-[(4-fluorophenyl)sulfonylamino]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-cyclohexyl-1-[[(2R,3R)-10-[(4-fluorophenyl)sulfonylamino]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-chloro-N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(pyridin-4-ylmethyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-pyridinecarboxamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 4-fluoro-N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2R,3R)-2-[[(4-fluorophenyl)sulfonyl-methylamino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-2-(1-methyl-3-indolyl)acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| 1-[(2R,3R)-2-[[benzenesulfonyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-[4-(trifluoromethyl)phenyl]urea | [no description available] | low | 0 | 0 | sulfonamide | |
| baricitinib | [no description available] | low | 0 | 0 | azetidines; nitrile; pyrazoles; pyrrolopyrimidine; sulfonamide | anti-inflammatory agent; antirheumatic drug; antiviral agent; EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor; immunosuppressive agent |
| 1-(4-methoxyphenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| 5,6-dimethyl-1-(4-methylphenyl)sulfonyl-2-benzimidazolamine | [no description available] | low | 0 | 0 | sulfonamide | |
| sr1001 | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-4-methoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| dabrafenib | [no description available] | low | 0 | 0 | 1,3-thiazoles; aminopyrimidine; organofluorine compound; sulfonamide | anticoronaviral agent; antineoplastic agent; B-Raf inhibitor |
| 3-[[4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-1,4-diazepan-1-yl]sulfonyl]aniline | [no description available] | low | 0 | 0 | benzenes; sulfonamide | |
| 4-[[(4-ethylphenyl)sulfonylamino]methyl]-N-[2-[(phenylmethyl)-propan-2-ylamino]ethyl]benzamide | [no description available] | low | 0 | 0 | sulfonamide | |
| EG00229 | [no description available] | low | 0 | 0 | benzothiadiazole; dicarboxylic acid monoamide; L-arginine derivative; secondary carboxamide; sulfonamide; thiophenes | angiogenesis inhibitor; antineoplastic agent; neuropilin receptor antagonist |
| gsk0660 | [no description available] | low | 0 | 0 | sulfonamide | |
| xl765 | [no description available] | low | 0 | 0 | aromatic amine; aromatic ether; benzamides; quinoxaline derivative; sulfonamide | antineoplastic agent; EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor; mTOR inhibitor |
| N-(3-chlorophenyl)-3-[[3,5-dimethyl-4-[(4-methyl-1-piperazinyl)-oxomethyl]-1H-pyrrol-2-yl]methylidene]-N-methyl-2-oxo-1H-indole-5-sulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| tipranavir | [no description available] | low | 0 | 0 | sulfonamide | antiviral drug; HIV protease inhibitor |
| abt-333 | [no description available] | low | 0 | 0 | aromatic ether; naphthalenes; pyrimidone; sulfonamide | antiviral drug; nonnucleoside hepatitis C virus polymerase inhibitor |
| pik 75 | [no description available] | low | 0 | 0 | sulfonamide | |
| vx-970 | [no description available] | low | 0 | 0 | sulfonamide | |
| pf-543 | [no description available] | low | 0 | 0 | sulfonamide | |
| ML355 | [no description available] | low | 0 | 0 | benzothiazoles; monomethoxybenzene; phenols; secondary amino compound; substituted aniline; sulfonamide | EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor; platelet aggregation inhibitor |
| sr9243 | [no description available] | low | 0 | 0 | bromobenzenes; sulfonamide; sulfone | antineoplastic agent; apoptosis inducer; liver X receptor inverse agonist |
| sildenafil | [no description available] | low | 0 | 0 | piperazines; pyrazolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
| da 8159 | [no description available] | low | 0 | 0 | sulfonamide | |
| 3-[[2-[4-(4-chlorophenyl)sulfonyl-1-piperazinyl]-2-oxoethyl]thio]-6-methyl-2H-1,2,4-triazin-5-one | [no description available] | low | 0 | 0 | sulfonamide | |
| N-tert-butyl-3-(3-tert-butyl-1-methyl-7-oxo-4H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxybenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[4-[2-[3-(dimethylsulfamoyl)anilino]-6H-1,3,4-thiadiazin-5-yl]phenyl]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-[(4-chlorophenyl)methylthio]-4-oxo-1H-pyrimidin-6-yl]benzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-[2-[(2-chlorophenyl)methylthio]-4-oxo-1H-pyrimidin-6-yl]-4-methylbenzenesulfonamide | [no description available] | low | 0 | 0 | sulfonamide | |
| N-(4-methoxyphenyl)-2-[[6-[(4-methylphenyl)sulfonylamino]-4-oxo-1H-pyrimidin-2-yl]thio]acetamide | [no description available] | low | 0 | 0 | sulfonamide | |
| mirodenafil | [no description available] | low | 0 | 0 | aromatic ether; N-alkylpiperazine; primary alcohol; pyrrolopyrimidine; sulfonamide | EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor; vasodilator agent |
| da-8164 | [no description available] | low | 0 | 0 | sulfonamide |
| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|---|---|---|---|
| Congenital Zika Syndrome | 0 | low | 1 | 0 |
| Congenital Zika Virus Infection | 0 | low | 1 | 0 |
| Disease Models, Animal | 0 | low | 1 | 0 |
| Fever, Zika | 0 | low | 1 | 0 |
| Zika Fever | 0 | low | 1 | 0 |
| Zika Virus Disease | 0 | low | 1 | 0 |
| Zika Virus Infection | 0 | low | 1 | 0 |
| ZikV Infection | 0 | low | 1 | 0 |
| Article | Year |
|---|---|
| Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens. The Journal of biological chemistry, 11-15, Volume: 294, Issue: 46 | 2019 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |